Futuremeds S.R.L.

At Futuremeds S.R.L. in Galati, research in dermatology focuses on atopic dermatitis and moderate-to-severe hidradenitis suppurativa. These studies are designed to evaluate how well new treatments control inflammation, improve symptoms, and help people who have not responded adequately to current care.

• Testing a new treatment option for atopic dermatitis when standard therapy has not worked well enough
• Assessing whether a therapy for hidradenitis suppurativa can better reduce disease burden than placebo

The site’s work in this area highlights efforts to improve treatment effectiveness for chronic, difficult-to-manage skin conditions.

Clinical research in nutritional and metabolic diseases at this Romanian site centers on obesity and type 2 diabetes. The trials are aimed at understanding whether new therapies can support meaningful weight reduction and improve metabolic health in adults.

• Evaluating a once-weekly treatment for obesity and overweight
• Studying whether the same approach may also benefit people living with type 2 diabetes

These studies reflect a strong interest in therapies that may help address long-term weight-related and metabolic conditions.

The site also participates in studies on cancer-associated cachexia, a serious condition linked to cancer-related weight loss and muscle wasting. This area of research is focused on testing whether investigational therapies can help preserve body mass, improve strength, and support overall well-being.

• Investigating a potential therapy for cachexia in people with cancer
• Exploring treatment options intended to improve nutritional and physical outcomes

At Futuremeds S.R.L., this work adds an important supportive-care dimension to the broader clinical trial portfolio.